Our photo tribute to Kay Van Norton Poche AO
Pictures tell a thousand words, and we are proud to share this photo tribute of Kay and her friendship with us over many years.
Preventing disease recurrence in BRAF positive melanoma patients
Final results of the COMBI-AD clinical trial, published in New England Journal of Medicine, show significant benefit in preventing disease progression in BRAF positive Stage III melanoma patients.
Vale Kay Van Norton Poche AO
It is with a heavy heart that we notify you that Kay Van Norton Poche AO, one of Melanoma Institute Australia's great friends and committed supporters, passed away on 14 June 2024, following a long illness.
‘Tour of Honour’ for our Australians of the Year
Our 2024 Australians of the Year recently explored the Northern Territory, as part of a visit organised by the Australia Day Council. View the photo album.
Official opening of new melanoma clinic in Riverina
Melanoma patients throughout the Riverina will benefit from strengthened melanoma services thanks to the newly opened MIA Amie St Clair clinic in Wagga, which includes a 3D full body imaging machine, clinic rooms and space for support groups and community events.
Community Fundraising teamwork and tributes
Read more about the inspiring stories behind our Community Fundraisers. Find out how you can fundraise to support melanoma research, which is also impacting other cancers.
MPA-MIA Melanoma Community Webinar Series 2024
Watch recordings of all three webinars in our 2024 webinar series - Sun protection after melanoma, Understanding the role of gut microbiome and Melanoma in situ.
Australian researchers spearhead cancer treatment revolution
In what has been described as a cancer treatment revolution, the pre-surgery use of combination immunotherapy looks to become standard treatment for melanoma and impact other cancers across the globe.